Immunogenicity of COVID-19 vaccines in patients with diabetes mellitus: A systematic review
Purpose To evaluate the immunogenicity of COVID-19 vaccines in patients with diabetes
mellitus (DM) through a systematic approach. Method A comprehensive search was …
mellitus (DM) through a systematic approach. Method A comprehensive search was …
COVID-19 pandemic and hypertension: an updated report from the Japanese Society of Hypertension project team on COVID-19
S Shibata, K Kobayashi, M Tanaka, K Asayama… - Hypertension …, 2023 - nature.com
The number of reported cases with coronavirus disease 2019 (COVID-19) has exceeded
620 million worldwide, still having a profound impact on people's health and daily lives since …
620 million worldwide, still having a profound impact on people's health and daily lives since …
Immunogenicity of mRNA-1273 COVID vaccine after 6 months surveillance in health care workers; a third dose is necessary
M Tré-Hardy, R Cupaiolo, A Wilmet… - Journal of Infection, 2021 - Elsevier
Objectives Scarce data are currently available on the kinetics of antibodies after vaccination
with mRNA vaccines as a whole and, with mRNA-1273, in particular. We report here an ad …
with mRNA vaccines as a whole and, with mRNA-1273, in particular. We report here an ad …
Poor neutralizing antibody responses in 132 patients with CLL, NHL and HL after vaccination against SARS-CoV-2: a prospective study
Simple Summary The urgency of the COVID-19 pandemic has led to accelerated vaccine
development within less than a year. Emerging data suggest that the ability of patients with …
development within less than a year. Emerging data suggest that the ability of patients with …
IgG antibodies against SARS-CoV-2 decay but persist 4 months after vaccination in a cohort of healthcare workers
G Brisotto, E Muraro, M Montico, C Corso… - Clinica Chimica …, 2021 - Elsevier
Background and aims Monitoring the immune response against SARS-CoV-2 is pivotal in
the evaluation of long-term vaccine efficacy. Immunoglobulin G (IgG) antibodies represent …
the evaluation of long-term vaccine efficacy. Immunoglobulin G (IgG) antibodies represent …
Reactogenicity Correlates Only Weakly with Humoral Immunogenicity after COVID-19 Vaccination with BNT162b2 mRNA (Comirnaty®)
J Held, J Esse, K Tascilar, P Steininger, K Schober… - Vaccines, 2021 - mdpi.com
mRNA vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
such as BNT162b2 (Comirnaty®), have proven to be highly immunogenic and efficient but …
such as BNT162b2 (Comirnaty®), have proven to be highly immunogenic and efficient but …
Plasma metabolomic alterations induced by COVID-19 vaccination reveal putative biomarkers reflecting the immune response
Vaccination is currently the most effective strategy for the mitigation of the COVID-19
pandemic. mRNA vaccines trigger the immune system to produce neutralizing antibodies …
pandemic. mRNA vaccines trigger the immune system to produce neutralizing antibodies …
Comparison of neutralizing antibody responses at 6 months post vaccination with BNT162b2 and AZD1222
Along with their level of protection against COVID-19, SARS-CoV-2-specific antibodies
decline over time following vaccination with BNT162b2. However, relevant data on …
decline over time following vaccination with BNT162b2. However, relevant data on …
Robust neutralizing antibody responses 6 months post vaccination with BNT162b2: a prospective study in 308 healthy individuals
Elucidating long-term immunity following COVID-19 vaccination is essential for decision-
making regarding booster shots. The aim of this study was to investigate the kinetics of …
making regarding booster shots. The aim of this study was to investigate the kinetics of …
[PDF][PDF] Six-month interim analysis of ongoing immunogenicity surveillance of the mRNA-1273 vaccine in healthcare workers: A third dose is expected
M Tré-Hardy, R Cupaiolo, A Wilmet… - J Infect, 2021 - dipot.ulb.ac.be
Objectives: Scarce data are currently available on the kinetics of antibodies after vaccination
with mRNA vaccines as a whole and, with mRNA-1273, in particular. We report here an ad …
with mRNA vaccines as a whole and, with mRNA-1273, in particular. We report here an ad …